Mumbai: TechInvention Lifecare Private Limited has been appointed. Consultant By Botswana Vaccine Institute (BVI) will have to monitor the installation of new state-of-the-art equipment cGMP Compliant, Vaccine manufacturing unit At your existing facility GaboroneBotswana.

Its scope is wide Project Management A key role for the state-owned Botswana Vaccine Institute (BVI), which has been manufacturing and supplying vital veterinary vaccines in the region and beyond since the 1970s.

The project involves setting up a new mix and fill block for veterinary vaccines, which will be compliant with cGMP requirements along with other stringent global standards and guidelines.

This initiative aims to increase the potency, number, quality, efficacy and safety of products, as well as ensure that all regulatory approvals are obtained, enabling the BVI to offer more products needed in the region and explore new markets.

The project will commence in 2022 and is expected to be completed and operational by 2026.

Syed Ahmed, CEO of TechInvention, expressed his full support to the BVI in making the proposed facility operational within the stipulated timeframe. He emphasised the territory’s strategic importance and the urgent need for such a facility.

Andrew MedswiThe BVI CEO reiterated the commitment to strengthen the capacity to manufacture a range of vaccines at the proposed state-of-the-art facility with cGMP compliance to ensure access to affordable, high-quality products for the country, the region and beyond.